http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
Shin Nishio,Satomi Aihara,Mototsugu Shimokawa,Akira Fujishita,Shuichi Taniguchi,Toru Hachisuga,Shintaro Yanazume,Hiroaki KOBAYASHI,Fumihiro Murakami,Fumitaka Numa,Kohei Kotera,Naofumi Okura,Naoyuki To 대한부인종양학회 2018 Journal of Gynecologic Oncology Vol.29 No.5
Objective: Palonosetron is effective for the management of acute and delayed chemotherapy-induced nausea and vomiting (CINV). While emetogenic carboplatin-based chemotherapy is widely used to treat gynecologic cancers, few studies have evaluated the antiemetic effectiveness of palonosetron in this setting. Methods: A multicenter, single-arm, open-label phase II trial was conducted to evaluate the safety and effectiveness of palonosetron in controlling CINV in patients with gynecologic cancer. Chemotherapy-naïve patients received intravenous palonosetron (0.75 mg/body) and dexamethasone before the infusion of carboplatin-based chemotherapy on day 1. Dexamethasone was administered (orally or intravenously) on days 2–3. The incidence and severity of CINV were evaluated using the patient-completed Multinational Association of Supportive Care in Cancer Antiemesis Tool and treatment diaries. The primary endpoint was the proportion of patients experiencing complete control (CC) of vomiting, with “no rescue antiemetic medication” and “no clinically significant nausea” or “only mild nausea” in the delayed phase (24–120 hours post-chemotherapy). Secondary endpoints were the proportion of patients with a complete response (CR: “no vomiting” and “no rescue antiemetic medication”) in the acute (0–24 hours), delayed (24–120 hours), and overall (0–120 hours) phases, and CC in the acute and overall phases. Results: Efficacy was assessable in 77 of 80 patients recruited. In the acute and delayed phases, the CR rates the primary endpoint, were 71.4% and 59.7% and the CC rates, the secondary endpoint, were 97.4% and 96.1%, respectively. Conclusion: While palonosetron effectively controls acute CINV, additional antiemetic management is warranted in the delayed phase after carboplatin-based chemotherapy in gynecologic cancer patients (Trial registry at UMIN Clinical Trials Registry, UMIN000012806).
이우승(Woo Sung Lee),서동환(Dong Hwan Suh),이하윤(Ha Yoon Lee),후지시다 노리유기(Fujishita Noriyuki) 한국원예학회 2013 원예과학기술지 Vol.31 No.4
Twenty and 16 accessions of the countrywide weedy melon (Cucumis melo var. agrestis) collections were evaluated in 1986 and 1990, respectively. There was a good variation in the plant height and their leaves were small in general. In sex expression, 30 of the accessions were andromonoecious, 4 were monoecious and 2 were hermaphrodite. Female flower set on main stems was extremely rare except for on hermaphrodite. On andromonoecious and monoecious plants, abundant female flowers set at the 1st and 2nd node of branch vines. Bitter taste was found in the young fruits of all the accessions tested. Mature fruits were dark yellow, yellow, light yellow or milky white in color, small in size, and very low in sweet taste. The number of seeds per fruit varied from 50.6 to 158.4 showing the characteristics of wild species for perpetuation in wild.